First Ascent Biomedical joins CancerX 2025 Accelerator
CancerX shared a post on LinkedIn:
“First Ascent Biomedical exemplifies the digital innovation in oncology that CancerX is committed to advancing – where cutting-edge technology meets biological insights to create truly personalized cancer care solutions.
This is why CancerX and KidsX are so happy to have them in the 2025 Accelerator!
They’re trying to revolutionize cancer treatment at the intersection of biology and technology with an innovative precision medicine platform.
First Ascent’s approach includes proprietary AI algorithms that analyze and match the biopsy pathology results with the most effective drugs for each specific patient, dramatically accelerating the path to effective treatment.
We’re excited to support First Ascent Biomedical as they work to make precision oncology more accessible and effective!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023